During the Phase I project, the PI has prepared florescent glutathione probes for the study of glutathione (GSH) receptors in the CNS. One of these probes shows promise as a potential replacement for radiolabelled GSH for the study of these receptors. In the Phase II portion of the project, the PI plans to continue preparation of such fluorescent probes with an ultimate aim toward not only maximizing the binding parameters for the GSH receptor but also with the aim of identifying that portion of the molecule which contributes to the binding to the receptor. In addition, the probes prepared by the PI will be used for comparison with radiolabelled GSH as a probe for studying the GSH receptor in astrocytes and/or human spinal cord.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
3R44NS032234-03S1
Application #
2536196
Study Section
Special Emphasis Panel (ZRG1-BPO (01))
Program Officer
Baughman, Robert W
Project Start
1994-03-01
Project End
1998-06-30
Budget Start
1996-03-01
Budget End
1998-06-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Covalent Associates, Inc.
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Shaw, C A; Pasqualotto, B A; Curry, K et al. (1999) A novel fluorescent GSH-adduct binds to the NMDA receptor. J Neurosci Methods 93:21-6